Bespoke Extracts (BSPK) Non Operating Income (2016 - 2025)
Bespoke Extracts (BSPK) reported Non Operating Income of -$24197.0 for Q3 2025, down 84.08% on a YoY basis from -$151968.3 in Q3 2024, and up 43.92% sequentially from -$43148.0 in Q2 2025.
Bespoke Extracts (BSPK) Non Operating Income (2016 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 10 years of Non Operating Income data on file, last reported at -$24197.0 in Q3 2025.
- For the quarter ending Q3 2025, Non Operating Income fell 84.08% year-over-year to -$24197.0; the trailing twelve-month figure through Sep 2025 stood at -$90263.0 (down 129.76% YoY), and the FY2024 full-year result was -$42847.0, down 294.36% from the prior year.
- Non Operating Income grew to -$24197.0 in Q3 2025, from -$43148.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $294917.0 in Q4 2021 to a low of -$96450.0 in Q4 2022.
- A 5-year average of $4362.3 and a median of -$6536.0 in 2023 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 1419.34% in 2023, while the deepest fall reached 1293.96% in 2023.
- Tracing BSPK's Non Operating Income over 5 years: stood at $294917.0 in 2021, then slumped by 132.7% to -$96450.0 in 2022, then soared by 95.67% to -$4173.0 in 2023, then slumped by 85.36% to -$7735.0 in 2024, then tumbled by 212.82% to -$24197.0 in 2025.
- Business Quant data shows BSPK's Non Operating Income at -$24197.0 in Q3 2025, -$43148.0 in Q2 2025, and -$15183.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -24,197.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -24,197.00 |
| Jun 30, 2025 | -43,148.00 |
| Mar 31, 2025 | -15,183.00 |
| Dec 31, 2024 | -7,735.00 |
| Sep 30, 2024 | -13,145.00 |
| Jun 30, 2024 | -10,652.00 |
| Mar 31, 2024 | -11,315.00 |
| Dec 31, 2023 | -4,173.00 |
| Sep 30, 2023 | -5,337.00 |
| Jun 30, 2023 | 2,587.00 |
| Mar 31, 2023 | 2,750.00 |
| Dec 31, 2022 | -96,450.00 |
| Sep 30, 2022 | 447.00 |
| Jun 30, 2022 | 250.00 |
| Mar 31, 2022 | 181.00 |
| Nov 30, 2021 | 294,917.00 |
| May 31, 2020 | -242,188.00 |
| Feb 29, 2020 | -365,251.00 |
| Nov 30, 2019 | -17,844.00 |
| Aug 31, 2019 | -1.00 |